Sudan's new drug policy proves its worth / H. M. Ali ... [et al.]
No Electronic Version
View StatisticsShow Statistical Information
Ali, H. M, Homeida, M. M. A, Rasheed, A. R. E & Bekele, A. (1986). Sudan's new drug policy proves its worth / H. M. Ali ... [et al.]. http://www.who.int/iris/handle/10665/47599
World health forum 1986 ; 7(3) : 256-260
MetadataShow full item record
Showing items related by title and MeSH subject.
Ali, H. M; Homeida, M. M. A; Rasheed, A. R. E; Bekele, A (1986)
Controlling medicine prices in Sudan: the challenge of the recently established Medicines Regulatory Authority Ali , G.K.M.; Yahia, A.Y. (2012)This study evaluated the capacity of the medicine pricing mechanism of the National Medicines and Poisons Board [NMPB], the medicine regulatory agency of Sudan, in controlling prices of imported medicines. The study was conducted between July and September 2008 and data on the 50 most sold medicines in 2007 were obtained from the records of the regulatory authority and pharmacies in Khartoum; 135 products were included. The cost and freight [CandF] prices of 23% of the selected medicines approved by NMPB were over 10 times the International ...
Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan Idris, K.M.; Mustafa, A.F.; Yousif, M.A. (2012)Pharmaceutical representatives are an important promotional tool for pharmaceutical companies. This cross-sectional, exploratory study aimed to determine pharmaceutical representatives' beliefs and practices about their professional practice in Sudan. A random sample of 160 pharmaceutical representatives were interviewed using a pretested questionnaire. The majority were male [84.4%] and had received training in professional sales skills [86.3%] and about the products being promoted [82.5%]. Only 65.6% agreed that they provided full and balanced ...